Siegfried

Siegfried is a company listed under the stock ticker SGFEF (CH).

View the org chart displaying its 15 main executives

Most searched biographies at Siegfried

• Wolfgang Wienand, Chief Executive Officer (until Jun 2024)
• Wolfram Carius, Director
• Andreas Casutt, Chairman of the Board

Popular executive movements at Siegfried

• Wolfgang Wienand, Chief Executive Officer, will leave the company in Jun. 2024  (posted on April 3 2024).
• Reto Suter who is Chief Financial Officer, will be promoted to Chief Financial Officer and Interim Chief Executive Officer on May 1, 2024  (posted on April 3 2024).

Create your alert
to follow the executive moves at Siegfried.

Siegfried has 1,862 competitors including Pfizer (United States (USA)), Sanofi (France) and Johnson & Johnson (United States (USA)).

Popular M&A news in Pharmaceuticals

• MedMen has filed for bankruptcy protection  (posted on April 28 2024).
• AstraZeneca has announced the acquisition of Fusion Pharma  (posted on March 23 2024).
• AstraZeneca has announced the acquisition of Amolyt Pharma  (posted on March 19 2024).

Popular contacts in Pharmaceuticals

• Jean-Frédéric Paulsen - Executive Chairman of the Board at Ferring Pharmaceuticals
• Thierry Abribat - Chief Executive Officer at Amolyt Pharma
• Emma Walmsley - Chief Executive Officer and Director at GSK

Learn more about the Pharmaceuticals industry >

Press releases by Siegfried

• News Subscription - Siegfried
• News Subscription - Siegfried

Social media about Siegfried

• Siegfried on Wikipedia, Google News & Yahoo Finance
• Siegfried on LinkedIn, Twitter & YouTube

Contact by email its executives including Wolfgang Wienand

Call Siegfried at +41 62...

View the org chart

Register to receive your alert

Report an error